Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase Gα oxidation

ISSN
0008-6363
Date Issued
2020
Author(s)
Kolijn, Detmar
Tian, Yanna
Lódi, Mária
Herwig, Melissa
Carrizzo, Albino
Zhazykbayeva, Saltanat
Kovács, Árpád
Fülöp, Gábor Á
Falcão-Pires, Inês
Reusch, Peter H
Linthout, Sophie Van
Papp, Zoltán
van Heerebeek, Loek
Vecchione, Carmine
Ciccarelli, Michele
Tschöpe, Carsten
Mügge, Andreas
Bagi, Zsolt
Hamdani, Nazha
DOI
10.1093/cvr/cvaa123